July 15 (Reuters) - Genetic Technologies Ltd (GTG) :
- GENETIC TECHNOLOGIES PROVIDES UPDATE ON COVID-19 DISEASE SEVERITY TEST
- GENETIC TECHNOLOGIES LTD - FILED A PROVISIONAL PATENT FOR ITS COVID-19 SEVERITY RISK TEST WITH PATENT OFFICE IN AUSTRALIA
- GENETIC TECHNOLOGIES - IN DISCUSSIONS WITH INTERNATIONAL BIOBANKS AND CLINICAL LABORATORIES TO SOURCE AN INDEPENDENT CROSS-VALIDATION DATASET
- GENETIC TECHNOLOGIES LTD - OPTIONS FOR CLINICAL RISK MODEL CURRENTLY BEING EVALUATED
- GENETIC TECHNOLOGIES LTD - COMMENCED ORDERING ITS FIRST SNP ARRAY PANEL FROM US-BASED THERMO FISHER SCIENTIFIC
- GENETIC TECHNOLOGIES LTD - CONFIRMED CAPACITY TO SCALE UP PRODUCTION FOR GLOBAL-ROLL OUT OF COVID-19 SEVERITY RISK TEST WITH MAJOR MANUFACTURERS
- Forums
- ASX - By Stock
- GTG
- News: GTG Genetic Technologies Files Provisional Patent For Its COVID-19 Severity Risk Test With...
News: GTG Genetic Technologies Files Provisional Patent For Its COVID-19 Severity Risk Test With...
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GTG (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.4¢ |
Change
0.001(2.33%) |
Mkt cap ! $6.398M |
Open | High | Low | Value | Volume |
4.4¢ | 4.4¢ | 4.4¢ | $98 | 2.228K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 15045 | 4.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.4¢ | 21048 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 15045 | 0.043 |
1 | 22522 | 0.041 |
2 | 62500 | 0.040 |
1 | 130000 | 0.038 |
1 | 27027 | 0.037 |
Price($) | Vol. | No. |
---|---|---|
0.044 | 21048 | 2 |
0.045 | 198603 | 2 |
0.046 | 750 | 1 |
0.055 | 30000 | 1 |
0.058 | 10000 | 1 |
Last trade - 11.37am 31/07/2024 (20 minute delay) ? |
Featured News
GTG (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online